This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2024 Oct 24;144(17):1762-1764.

doi: 10.1182/blood.2024026116.

Abatacept vs PT-Cy for GVHD prophylaxis

Frédéric Baron¹

Affiliations

PMID: 39446374
DOI: 10.1182/blood.2024026116

Free article

Comment

Abatacept vs PT-Cy for GVHD prophylaxis

Frédéric Baron. Blood. 2024.

Free article

. 2024 Oct 24;144(17):1762-1764.

doi: 10.1182/blood.2024026116.

Author

Frédéric Baron¹

Affiliation

¹ University of Liege and Centre Hospitalier Universitaire of Liege.

PMID: 39446374
DOI: 10.1182/blood.2024026116

No abstract available

PubMed Disclaimer

Comment on

Abatacept for acute graft-versus-host disease prophylaxis after unrelated donor hematopoietic cell transplantation.
Kean LS, Burns LJ, Kou TD, Kapikian R, Lozenski K, Langston A, Horan JT, Watkins B, Qayed M, Bratrude B, Betz K, Tang XY, Zhang MJ, Connolly SE, Polinsky M, Gavin B, Gomez-Caminero A, Pasquini MC. Kean LS, et al. Blood. 2024 Oct 24;144(17):1834-1845. doi: 10.1182/blood.2023023660. Blood. 2024. PMID: 39028876 Free PMC article.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Silverchair Information Systems